Trials / Completed
CompletedNCT00623363
Preliminary Study of Piclozotan in Patients With Motor Complications Associated With Parkinson's Disease
A Double-Blind, Placebo-Controlled, Preliminary Study of the Efficacy, Safety, and Tolerability of Intravenous SUN N4057 in Patients With Motor Complications Associated With Parkinson's Disease
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 27 (actual)
- Sponsor
- Daiichi Sankyo · Industry
- Sex
- All
- Age
- 40 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to obtain preliminary information on the effect of piclozotan on motor complications associated with Parkinson's Disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | piclozotan | piclozotan, intravenous (IV) infusion |
| DRUG | 0.9% sodium chloride (normal saline) | 0.9% sodium chloride (normal saline) intravenous (IV) infusion |
Timeline
- Start date
- 2007-07-13
- Primary completion
- 2008-07-17
- Completion
- 2008-07-17
- First posted
- 2008-02-26
- Last updated
- 2021-03-11
- Results posted
- 2021-03-11
Locations
7 sites across 3 countries: United States, Guatemala, Romania
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT00623363. Inclusion in this directory is not an endorsement.